Gil Friedlander

Investor at Laminate Medical Technologies Ltd.

📍 Israel🔄 Updated September 2026💼 25 investments📅 6 years investing🗓 Last invested Apr 2026
VC🌍 Israel20+ investmentsInvested this year
25
Total investments
4
Early stage
6
Mid stage
11
Late stage
6y
Years active

Portfolio

23 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Apr 2026
Scala Biodesign stands at the forefront of the current revolution in protein design. Scala’s no-code one-shot software enables R&D teams to design their proteins in a single design cycle, increasing success rates, reducing R&D effort, and accelerating time-to-market. Scalas technologies, developed by its founding team at the Weizmann Institute of Science, are backed by an unprecedented record of over 130 peer-reviewed publications and collaborations with 80 commercial and academic partners. This includes the first-ever one-shot design of a malaria vaccine candidate, now advancing through Phase II clinical trials, and proteins that were previously considered out of reach across biotherapeutics, enzymes for biomanufacturing, diagnostics, and other bio-based products. Utilizing this unique edge, Scala aims to disrupt the field and democratize the way proteins are developed. Scala has already partnered with five of the top-20 pharmaceutical companies and other market leaders across multiple verticals.
Investor
Feb 2026
We drive improvement to your Stars performance with our Behavioral AI Stars Platform. As you feed your data into our behavioral insights engine, it uses a combination of behavioral science, quality expertise and AI-assisted prioritization to create a dynamic working record of your membership. We use this information to create individualized member outreach at scale, automatically prioritizing the right measure, the right intervention and the right message to ensure the most effective action is taken with quality improvements in mind. With expertise and full orchestration across all interventions, we can also integrate other outreach vendors or in-house solutions to give you one clear picture of what is happening with each member. And, we continuously adjust and improve these capabilities to maximize value, revenue and Star Ratings.
Investor
Mar 2025
Quietly building whats next for defense.
Investor
Feb 2025
IBI-Ag is an Israeli-based company addressing food protection challenges with novel biocontrol solutions. We use a novel biological active ingredient, combined with a new mode of action for developing a new class of bio-insecticides. IBI-Ags novel biological solution for insect control allowing precise pest control of any given insect with a safe mode of action and minimal environmental traces.
Investor
Jan 2025
Medium Well is on the brink of revolutionizing the FoodTech industry with our cutting-edge molecular separation solution! BioResin is a natural cost effective matrix that can seperate molecules based on charge and size and easily integrates into the DSP. Were dedicated to addressing the demands of the emerging alternative protein sector. By streamlining costs, facilitating scalability, and reducing waste, were poised to accelerate products to market. Our game-changing proprietary molecular seperation solution is poised to transform the downstream process for protein purification to much nore cost effective! We offer an innovative solution for medium management in cultivated meat and enhance protein separation in fermentation production. Our exceptional ultra-filtration capabilities rely on a natural, cost-effective biofilter that selectively extracts specific molecules from liquids. In precision fermentation, for food and pharma, our BioResin offers a 10-20X lower cost, large scale solution to protein purification than the current synthetic resins on the market. In the realm of cultivated meat, we remove toxicants like ammonium and lactic acid and optimize medium usage. Our work is fueled by Dr. Roni Shapiras pioneering microbiology research lab at the Hebrew university. The engineering efforts are spearheaded by Dr. Nir Berdugo, an expert in applied mathematics and water recycling, alongside the professional support of our design partners, working hand in hand with the industry. Since 2022, under the visionary leadership of Shelly Lotan, Adv., our co-founder, and CEO, we have garnered support from key stakeholders, including the Israeli Innovation Authority, Fresh Start FoodTech incubator, Tnuva (Israels largest food manufacturer), Tempo (a leading beverage company), OurCrowds investment platform, and Finistere Ventures, the international agrifood venture capital firm. Connect with us and lets redefine the industry together. #MediumWellTech
Board Member & Investor
Jan 2025
Airwayz is a defense-grade airspace technology company building the operational infrastructure for the low-altitude airspace era. Founded in 2019 by Israeli Air Force veterans with deep expertise in air traffic management and command and control, we make complex airspace safe, governed, and commercially viable — for everyone operating in it. Our platform connects, orchestrates, and governs every sensor, effector, drone operator, and agency in the low-altitude airspace — from AI-assisted mission planning through real-time coordinated response to post-incident audit. We operate where most systems stop.
Investor
Dec 2024
Hoopo is recognized as a global leader in asset intelligence solutions, setting new standards with its state-of-the-art technology. Hoopo’s cutting-edge tracking solutions provide real-time visibility into your unpowered asset fleet, empowering businesses to optimize operations and enhance efficiency. With a portfolio of three unique trackers, Hoopo has the tracking solution to fit your operational needs. Learn more about our tracker at our website: www.hoopo.tech.
Investor
Dec 2024
Ballerine is an AI-powered risk and compliance platform that helps the worlds leading financial institutions, payment platforms, and acquirers onboard merchants faster, reduce costs, and ensure compliance at scale. By unifying KYB, merchant fraud detection, and global adaptability into a configurable workflow, Ballerine enables confident, real-time decision-making in an increasingly complex regulatory landscape.
Investor
Nov 2024
Covercy is the first real estate syndication platform where banking meets investment management. Save time with our automated distribution & capital call payment processing, gain your LPs’ trust with our intuitive Investor Portal, and generate interest from capital funds held in your Covercy Wallet – all in one platform. Covercy is backed by Silvertech Ventures, Group 11 and Altair VC. The company has offices in New York, London and Tel Aviv. Covercy is a financial technology company. Payment & banking services provided by our regulated partners.
Investor
Sep 2024
Precise Bio develops and commercializes 4D bio-fabricated functional tissues and organs that can save lives and improve its quality. We combine world-class tissue-engineering and transplantation experience with best-in-class bio-printing, to create a scalable bio-fabrication platform, that can overcome current industry challenges and make complex human organs available for transplantation.
Investor
Aug 2024
Repeat Sales Intelligence Platform for E-Commerce. At Bark-AI, we specialize in discovering which products, incentives, channels, and timing are most effective in converting first-time buyers into repeat customers. By connecting your E-commerce solution, analytics tools, and marketing automation platform, we empower you to analyze your performance, benchmark against your industry, forecast revenues, analyze discounts, and strategically plan your campaigns to enhance repeat sales.
Investor
Jul 2024
illumex empowers enterprises to confidently deploy AI agents that deliver reliable, explainable, and compliant decisions at scale. Its Generative Semantic Fabric (GSF) platform transforms an enterprise’s organizational corpus of knowledge into AI-ready, business context embedded into semantic ontologies. These ontologies, which serve as a basis for data management, analytics, and agentic workflows, orchestrate AI agents to collaborate around shared context (via MCP) and interpret prompts with precision – eliminating hallucinations, ensuring compliance, and reducing TCO by up to 80%. Named a Gartner Cool Vendor in Agentic AI for Data Management and Tech Pioneer in AI Governance by World Economic Forum, illumex is setting the new standard for unified governed semantic data infrastructure in the age of agentic AI. illumex was founded by Inna Tokarev Sela, former Senior Director of Machine Learning at SAP, who brings two decades of experience leading large-scale initiatives to leverage data and AI.
Investor
Jul 2024
Addionics is a growing, progressive startup based in Israel, the UK and the US. Addionics provides specialised improved rechargeable batteries by redesigning their architecture. With a novel and patent pending 3D metal fabrication method, we enhance performance, mileage, safety, cost and charging time of batteries. Addionics architecture work with current and emerging LIB technology. In short - we are betting on the race, not the horse. So whatever battery chemistry wins, our technology will enhance it yet further. There are two sides to the company - hardware making smart 3D current collectors, and software where AI will optimise given structures for given performance attributes.
Investor
May 2024
Hyperspace is a high-performance hybrid (lexical and vector) information retrieval solution engineered to handle large-scale workloads with exceptional speed and efficiency. As a cloud-native database, it empowers developers, enterprises, and Gen AI applications to retrieve both structured and unstructured data, driving business value through improved customer satisfaction, optimized LLM models, and the full unlocking of Gen AI’s potential. By combining domain-specific computing with the power of specialized processors like GPUs and FPGAs for customizable tasks, Hyperspace achieves unparalleled efficiency. These processors use custom instructions optimized for specific tasks, therefore reducing the stack overhead and ensuring far greater performance and cost-effectiveness than general-purpose CPUs.
Investor
May 2024
UltraSight aims to revolutionize cardiac sonography through the power of machine learning to enable more accurate and timely clinical decisions. UltraSight’s AI-driven software provides real-time guidance and quality assessment to allow healthcare professionals, regardless of sonography proficiency, to consistently perform high-quality cardiac ultrasound in a variety of settings at the point of care, including clinics, community hospitals, ambulances, and remote and rural areas. UltraSight’s AI real-time guidance software has FDA 510(k) Clearance, is UKCA and CE Marked, and has Israeli AMAR Clearance to assist medical professionals in performing cardiac ultrasound scans. UltraSight’s software is an accessory to compatible general-purpose, diagnostic ultrasound systems. Full labeling is available at https://ultrasight.com/regulatory-approvals-and-labeling/. In 2022, UltraSight won the Bristol Myers Squibb Improving Cardiovascular Disease Outcomes Challenge as the most "innovative cardiac technology." Additionally, the company was awarded a patent for its real-time guidance solution for ultrasound devices.
Show all 23 investments ↓
Experience · 31 entries
All (31)
Investments (25)
Founder (4)
Board (3)
2026
Investor
Apr 2026
Scala Biodesign stands at the forefront of the current revolution in protein design. Scala’s no-code one-shot software enables R&D teams to design their proteins in a single design cycle, increasing success rates, reducing R&D effort, and accelerating time-to-market. Scalas technologies, developed by its founding team at the Weizmann Institute of Science, are backed by an unprecedented record of over 130 peer-reviewed publications and collaborations with 80 commercial and academic partners. This includes the first-ever one-shot design of a malaria vaccine candidate, now advancing through Phase II clinical trials, and proteins that were previously considered out of reach across biotherapeutics, enzymes for biomanufacturing, diagnostics, and other bio-based products. Utilizing this unique edge, Scala aims to disrupt the field and democratize the way proteins are developed. Scala has already partnered with five of the top-20 pharmaceutical companies and other market leaders across multiple verticals.
Investor
Apr 2026
Laminate Medical Technologies is committed to advancing arteriovenous fistula (AVF) function for hemodialysis patients globally. Laminate’s flagship product, VasQ™, is an extravascular support designed to improve surgical fistula outcomes by providing permanent reinforcement to the artery-vein connection, promoting stability against wall tension, and decreasing turbulent flow. To learn more about VasQ, visit https://www.laminatemedical.com/.
Investor
Feb 2026
We drive improvement to your Stars performance with our Behavioral AI Stars Platform. As you feed your data into our behavioral insights engine, it uses a combination of behavioral science, quality expertise and AI-assisted prioritization to create a dynamic working record of your membership. We use this information to create individualized member outreach at scale, automatically prioritizing the right measure, the right intervention and the right message to ensure the most effective action is taken with quality improvements in mind. With expertise and full orchestration across all interventions, we can also integrate other outreach vendors or in-house solutions to give you one clear picture of what is happening with each member. And, we continuously adjust and improve these capabilities to maximize value, revenue and Star Ratings.
2025
Investor
Mar 2025
Quietly building whats next for defense.
Investor
Feb 2025
IBI-Ag is an Israeli-based company addressing food protection challenges with novel biocontrol solutions. We use a novel biological active ingredient, combined with a new mode of action for developing a new class of bio-insecticides. IBI-Ags novel biological solution for insect control allowing precise pest control of any given insect with a safe mode of action and minimal environmental traces.
Show all 31 entries ↓
Investment activity
2020–2026 · 25 investments
202022024162025420263
Recent (last 2 years)Earlier